Eric Rose

Eric Rose

Chief Tech/Sci/R&D Officer bei MESOBLAST LIMITED

Vermögen: 11 431 $ am 31.03.2024

73 Jahre
Health Technology
Finance
Consumer Services

Profil

Eric A.
Rose
is the founder of VTVX Holdings I LLC.
He currently holds the position of Chairman at LongView Ventures LLC.
Additionally, he is the Executive Director & Chief Medical Officer at Mesoblast Ltd., Director at Orchestra BioMed, Inc., Non-Executive Director at Orchestra Biomed Holdings, Inc., and Advisor at KBL Healthcare Ventures.
He is also a member of the Strategic Advisory Board at Broadview Ventures, Inc. In the past, he served as Chairman at SIGA Technologies, Inc., Chairman-Surgery Department at NewYork-Presbyterian Hospital, Chairman-Health Evidence & Policy Department at Icahn School of Medicine at Mount Sinai, Chairman-Surgery Department at Columbia University College of Physicians & Surgeons, and Independent Director at ABIOMED, Inc. He has also held positions as a Director at Nexell Therapeutics, Inc., Keryx Biopharmaceuticals, Inc., Nephros, Inc., CircuLite, Inc., PharmaCore, Inc., and the National Preparedness & Response Science Board.
He was the President of the International Society for Heart & Lung Transplantation and served as Executive Vice President-Life Sciences at MacAndrews & Forbes LLC and MacAndrews & Forbes Holdings, Inc. Dr. Rose received his undergraduate and doctorate degrees from Columbia University College of Physicians & Surgeons.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
22.03.2024 2 169 ( 0,01% ) 11 431 $ 31.03.2024
10.01.2024 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Eric Rose

UnternehmenPositionBeginn
MESOBLAST LIMITED Chief Tech/Sci/R&D Officer 01.02.2022
ORCHESTRA BIOMED HOLDINGS, INC. Director/Board Member 26.01.2023
LongView Ventures LLC Chairman -
Consultant / Advisor -
Director/Board Member 01.12.2018
Corporate Officer/Principal 01.01.2007
Consultant / Advisor -
Alle aktiven Positionen von Eric Rose

Ehemalige bekannte Positionen von Eric Rose

UnternehmenPositionEnde
ABIOMED, INC. Director/Board Member 22.12.2022
SIGA TECHNOLOGIES, INC. Chief Executive Officer 13.10.2016
░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Eric Rose im Detail an

Ausbildung von Eric Rose

Columbia University College of Physicians & Surgeons Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Eric Rose im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
SIGA TECHNOLOGIES, INC.

Health Technology

NEPHROS, INC.

Health Technology

MESOBLAST LIMITED

Health Technology

ORCHESTRA BIOMED HOLDINGS, INC.

Health Technology

Private Unternehmen15

Health Technology

Health Technology

Health Technology

Commercial Services

Distribution Services

International Society for Heart & Lung Transplantation

Health Services

Finance

Finance

Health Technology

Finance

Finance

National Preparedness & Response Science Board

Health Technology

LongView Ventures LLC

Sehen Sie sich die Unternehmensverbindungen an